Maleimide - CAS 541-59-3
Catalog: |
BB028532 |
Product Name: |
Maleimide |
CAS: |
541-59-3 |
Synonyms: |
pyrrole-2,5-dione |
IUPAC Name: | pyrrole-2,5-dione |
Description: | Maleimide (CAS# 541-59-3) is a compound useful in organic synthesis. |
Molecular Weight: | 97.07 |
Molecular Formula: | C4H3NO2 |
Canonical SMILES: | C1=CC(=O)NC1=O |
InChI: | InChI=1S/C4H3NO2/c6-3-1-2-4(7)5-3/h1-2H,(H,5,6,7) |
InChI Key: | PEEHTFAAVSWFBL-UHFFFAOYSA-N |
Boiling Point: | 97-103 ℃ / 5 mmHg |
Melting Point: | 90-94 ℃ |
Purity: | 98 % |
Density: | 1.2493 g/cm3 |
Solubility: | 9 [ug/mL] (The mean of the results at pH 7.4) |
Appearance: | Slight yellow crystalline powder |
Storage: | Refrigerator |
MDL: | MFCD00005494 |
LogP: | -0.47220 |
Vapor Pressure: | 0.00000277 [mmHg] |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P260, P261, P264, P270, P272, P280, P301+P310, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P330, P333+P313, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
US-2019270806-A1 | Il-6 antibodies and fusion constructs and conjugates thereof | 20180302 |
US-2018334496-A1 | Complement factor d antagonist antibodies and conjugates thereof | 20170414 |
US-2017190766-A1 | Antibodies and conjugates thereof | 20151230 |
US-11066465-B2 | Antibodies and conjugates thereof | 20151230 |
US-2021324063-A1 | Antibodies and conjugates thereof | 20151230 |
PMID | Publication Date | Title | Journal |
28671458 | 20170810 | Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors | Journal of medicinal chemistry |
24327518 | 20140201 | Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer | Molecular cancer therapeutics |
23384038 | 20130220 | An arsenical-maleimide for the generation of new targeted biochemical reagents | Journal of the American Chemical Society |
23046752 | 20130101 | Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes | Biomaterials |
23022153 | 20121201 | Propylbenzmethylation at Val-1(α) markedly increases the tetramer stability of the PEGylated hemoglobin: a comparison with propylation at Val-1(α) | Biochimica et biophysica acta |
Complexity: | 132 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 97.016378338 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 97.016378338 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 46.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS